Sex-dependent differences have been consistently described in cannabinoid addiction research. In particular, we recently reported that female Lister Hooded rats display greater self-administration of the cannabinoid CB1 receptor agonist WIN55,212-2 (WIN) and stronger reinstatement of cannabinoid-seeking behavior than males. Cannabinoids modulate the phosphorylation of the extracellular-signalregulated kinase (ERK) pathway, leading to various forms of plasticity-related learning that likely affect operant behavior. However, whether or not the reported sex-dependent differences in cannabinoid-taking and cannabinoid-seeking behaviors may be related to a sexual dimorphic activation of the ERK pathway remains still to be determined. In the present study, we measured the level of phosphoERKpositive cells in the cingulate cortex (CG1), prefrontal cortex (PFCx), and nucleus accumbens of male and of intact (i.e. sham-operated) and ovariectomized female Lister Hooded rats 30 and 60 min after an acute, intravenous, injection of a dose of WIN (0.3 mg/kg) resembling the mean amount of drug daily self-administered by trained rats. We found that WIN significantly increased ERK activation in the CG1, PFCx, and nucleus accumbens in a sex time and, restricted to the cortical areas, layer-specific manner.
Introduction
Drugs of abuse affect numerous brain nuclei altering neurotransmission and intracellular signaling cascades, which ultimately may result in maladaptive synaptic plasticity and abnormal behaviors. Extracellular-signalregulated kinase (ERK) belongs to the family of mitogenactivated protein kinases, which are involved in the regulation of synaptic plasticity, associative learning, and drug addiction (Zamora-Martinez and Edwards, 2014) . ERK is significantly activated following exposure to psychoactive compounds in the cingulate cortex (CG1), prefrontal cortex (PFCx), and nucleus accumbens (Acb) subregions (Acquas et al., 2010; Rosas et al., 2014; Giorgi et al., 2015) and is upregulated by a single administration of cannabinoid CB1 receptor (CB1R) agonists in several rodent brain regions (Valjent et al., 2001; Derkinderen et al., 2003) . In agreement with the strain dependency in the self-administration of the synthetic CB1R agonist WIN55,212-2 (WIN) (Deiana et al., 2007) , extracellularsignal-regulated kinase phosphorylation (pERK) also appears strain-dependent (Brand et al., 2012) , suggesting that a differential ERK pathway activation by cannabinoids might contribute to the strain differences observed in cannabinoid-induced reward sensitivity and behavioral effects (Chen et al., 1991) .
Sex-dependent differences in brain CB1R density and functionality (Castelli et al., 2014) and in cannabinoidinduced behavioral effects (Fattore, 2013) , including cannabinoid intravenous self-administration and reinstatement of cannabinoid-seeking , have been consistently described in Lister Hooded rats. In the same strain, a tonic endocannabinoid signaling was found to modulate the inhibitory afferents impinging upon dopamine neurons in the ventral tegmental area of female but not male rats (Melis et al., 2013) . Nevertheless, whether or not sex-dependent differences also exist in the activation of ERK following exposure to cannabinoids was not investigated. On the basis of these premises, this study investigated potential sex-dependent differences in cannabinoid-induced ERK activation in the superficial and deep layers of the CG1, in the prelimbic (PrL) and infralimbic (IL) subregions of the PFCx, and in the shell (AcbSh) and core (AcbC) subregions of the Acb. Lister Hooded rats were used because sex-dependent differences in WIN self-administration and tonic endocannabinoid signaling (Melis et al., 2013) have been described in this specific strain. The dose of the CB1R agonist used (WIN, 0.3 mg/kg) was in the range of those self-administered daily by rats of this strain (Deiana et al., 2007; Fattore et al., 2007 . Moreover, as fluctuations in estrogen levels during the female estrous cycle are known to alter ERK activation (Bi et al., 2003) , we also evaluated the modulating influence of ovarian hormones in the pattern of WIN-dependent ERK activation in female rats. To this end, the number of pERK-positive neurons was measured in the above-mentioned brain subregions of male and of intact and ovariectomized (OVX) female rats at two different time points (30 and 60 min) after WIN administration to assess potential time-dependency in WIN-induced activation of ERK.
Methods

Subjects
Male and female Lister Hooded rats (250-300 g at the beginning of the study; Envigo, Udine, Italy) were used. After arrival, animals were housed four per cage in a temperature (21 1°C) and humidity-controlled (60 10%) room under a reversed 12-h light/dark cycle (light on from 7 : 00 p.m.), with water and food available ad libitum. After ovariectomy and implantation of a permanent intravenous catheter, rats were housed individually and allowed to recover. All experimental procedures took place during the dark phase of the cycle and were carried out in accordance with the Principles of laboratory animal care (NIH publication no. 85-23, revised 1985) , the European Communities Council Directive (2010/63/UE), and the local Animal Care Committee regulations. All efforts were made to minimize animal suffering and reduce their number.
Surgery Ovariectomy
Under deep anesthesia (isoflurane 2%), two groups of rats were either OVX or sham operated as previously described . After surgery, OVX rats received a daily subcutaneous administration of 0.1 ml of enrofloxacin (Baytrill) for at least 5 days as postsurgery therapy. Both intact (i.e. sham-operated) and OVX female rats were left undisturbed for 3 weeks to stabilize gonadal and pituitary hormones in the OVX group before undergoing the surgery for intravenous catheter implantation.
Intravenous catheter implantation
Under deep anesthesia with isoflurane (2%), male, female, and OVX rats were surgically implanted with a chronic indwelling silastic catheter (CamCaths, Cambridge, UK) into the right external jugular vein. The catheter was passed under the skin, threaded out of an incision made on the back in midscapular region, and fixed with two sutures. After surgery, each rat, individually housed, received a daily administration of 0.1 ml of enrofloxacin for 7 days as postsurgery therapy.
Perfusion
After 30 or 60 min from intravenous administration, rats were deeply anesthetized with an intraperitoneal injection of equithesin (0.97 g pentobarbital, 2.1 g MgSO 4 , 4.25 g chloral hydrate, 42.8 ml propylene glycol, 11.5 ml ethanol 90%; 0.5 ml/kg) and transcardially perfused with ice-cold PBS (137 mmol/l NaCl, 2.7 mmol/l KCl, 10 mmol/l Na 2 HPO 4 , 2 mmol/l KH 2 PO 4 ; pH 7.4) followed by 4% paraformaldehyde. Brains were carefully removed and postfixed in 4% paraformaldehyde overnight at 4°C. Brain sections (40 µm) of the regions of interest (CG1, PrL PFCx, IL PFCx, AcbSh, and AcbC) were cut, according to the Paxinos and Watson (1998) rat brain atlas, in ice-cold PBS with a vibratome (Leica VT1000; Leica, Frankfurt, Germany) and either kept in icecold PBS or stored in a cryoprotective solution.
pERK immunohistochemistry
As previously described (Marotta et al., 2014; Rosas et al., 2014) , after 30 min of incubation in H 2 O 2 (1%), sections were incubated again for 1 h with 3% BSA. Incubation with the primary antibody (anti-pERK, 1 : 350; Cell Signaling Technology, Danvers, Massachusetts, USA) was conducted overnight at 4°C. On the following day, sections were first rinsed and then incubated for 1 h with the biotinylated secondary antibody (1 : 800; Sigma Aldrich S.R.L., Milan, Italy). Sections were rinsed again and incubated in an avidin biotin peroxidase complex prepared according to the manufacturer's suggestions (Vectastain ABC kit; Vector Laboratories Inc., Burlingame, California, USA); a 3-3′-diaminobenzidine solution (10 mg/ml) was added until a brown stain developed. Sections were rinsed and mounted onto gelatin-coated slides and processed through alcohol-xylene for light microscopy examination. pERK-positive neurons were identified in the regions of interest at the lowest magnification (×10) and quantitative analysis was performed using a light microscope Zeiss Axioskop-40 equipped with PL Fluotar × 10 (NA = 0.3, Carl Zeiss Microscopy GmbH, Munich, Germany) objective coupled with a digital camera (PixeLink, PL-A686C, 6.6 megapixels, Pixelink Inc, Ottawa, Ontario, Canada). Representative images at low (×10) magnification of pERKpositive neurons from CG1, PFCx (PrL and IL), and Acb (AcbSh and AcbC) of male and female rats after administration of vehicle (veh, 0.1 ml) or WIN (0.3mg/kg) are shown in Fig. 1 . pERK-positive cells (with no distinction of cell types) were separately assayed from deep and superficial layers of the CG1 and PFCx. The average SEM number of pERKpositive neurons/area following WIN administration was calculated as percent change with respect to the average number of pERK-positive neurons/area of the corresponding control (veh-administered) groups, set as 100%.
-benzoxazinyl]-1-naphtalenyl-methanone mesylate (WIN55,212-2; RBI, Natick, Massachusetts, USA) was dissolved in one drop of Tween80, diluted in heparinized (1%) saline solution and administered intravenously at a dose of 0.3 mg/kg (injection volume: 0.1 ml) 30 or 60 min before anesthesia for transcardiac perfusion. Control groups received an intravenous infusion of veh (0.1 ml) before being anaesthetized for perfusion at the same time intervals. Anesthetics and antibiotics were purchased from local suppliers.
Statistics
Data were analyzed by one-way, two-way, or three-way analysis of variance (ANOVAs) with %average numbers of pERK-positive neurons/area as the dependent variable 
Representative images of phosphorylated extracellular-signal-regulated kinase-positive neurons from CG1, PrL PFCx, and IL PFCx of female rats at 30 min (a-b; e-f) and of male rats at 60 min (c-d; g-h) and from AcbSh and AcbC of male rats at 30 min (i-l) at low (×10) magnification after administration of vehicle (left) and WIN (0.3 mg/kg, intravenous) (right). Aca, anterior commissure, anterior part; Acb, nucleus accumbens; AcbC, core subregion of the nucleus accumbens; AcbSh, shell subregion of the nucleus accumbens; CG1, cingulate cortex; fmi, forceps minor corpus callosum; IL, infralimbic region; PFCx, prefrontal cortex; PrL, prelimbic region; WIN, WIN55,212-2. Scale bar indicates 100 µm.
Sex differences in CB-induced ERK Rosas et al. 475 and with Time, Treatment, and Sex/Hormonal status as the independent variables. When allowed by significant main effects and interactions, Newman-Keuls post-hoc analysis was applied for multiple comparisons, with the statistical significance set at a P value less than 0.05.
Results
Effects of WIN-55,212-2 on ERK activation in the CG1 WIN administration significantly affected the level of pERK-positive neurons in the CG1 in a sex hormonal status time and layer-dependent manner. Specifically, 30 min after WIN administration (Fig. 2, top (Fig. 2 , top panels, left) were significantly different from control (veh-treated) females and from WIN-administered male and OVX rats (P < 0.05) and that (ii) the effects of WIN in the deep layer of male rats at 60 min (Fig. 3 , top panels, right) were significantly different from control (veh-treated) males and from WIN-administered female rats. Importantly, the effects of WIN, observed at 30 min (in female rats) and at 60 min (in male rats), were significantly different (P < 0.05) from those observed in the same-sex groups at 60 and 30 min, respectively.
Effects of WIN-55,212-2 on ERK activation in the PFCx
Administration of WIN induced sex hormonal status time and layer-dependent significant increases in the level of pERK-positive neurons in the PFCx. Specifically, 30 min after WIN administration (Fig. 2) the level of pERKpositive neurons was significantly increased in female rats in the superficial layer of both the PrL PFCx (+ 171%, middle panels, left) and the IL PFCx (+ 115%, bottom panels, left), but unchanged in the deep layers of all groups (right panels). Conversely, 60 min after WIN administration (Fig. 3) pERK-positive neurons were significantly augmented in the superficial (+ 100%, left panels) and deep layers (+ 193%, right panels) of the PrL PFCx (middle panels) and in the superficial (+ 98%, left panels) and deep layers (+ 210%, right panels) of the IL PFCx (bottom panels) of male rats, but unchanged in intact and OVX females. Notably, WIN-induced ERK activation in the superficial layers of both PrL and IL PFCx was affected by ovarian hormones, being significantly different between intact and OVX female rats at 30 min (Fig. 2, right panels) . Fig. 2) (i) the effects of WIN in the superficial layer of the PrL PFCx of female rats (middle panels, left) were significantly different from control (veh-treated) females and from WINadministered males and OVX females (P < 0.05) and that (ii) the effects of WIN in the superficial layer of the IL PFCx of female rats (bottom panel, left) were significantly different from control (veh-treated) females and from WIN-administered OVX (P < 0.05). Post-hoc analyses also revealed that at 60 min ( Fig. 3) (i) the effects of WIN on both the superficial and deep layers of PrL PFCx of male rats (middle panels) were significantly different from control (veh-treated) males and from WINadministered female rats, (ii) the effects of WIN in the superficial layers of IL PFCx of male rats (bottom panel, left) were significantly different from control (veh-treated) males, and (iii) the effects of WIN in the deep layer of IL PFCx of male rats (bottom panel, right) were significantly different from control (veh-treated) males and from WIN-administered female rats. Moreover, the effects of WIN detected at 30 min (Fig. 2) in the superficial layer of female rats were significantly different from those observed at 60 min (Fig. 3) , whereas those detected at 60 min in the superficial (PrL) and deep (PrL and IL) layers in male rats were significantly different (P < 0.05) from those at 30 min.
The effects induced by WIN administration on the activation of ERK in the two cortical areas examined are summarized in Table 1 .
Effects of WIN-55,212-2 on ERK activation in the Acb
As shown in Fig. 4 , administration of WIN significantly increased the level of pERK-positive neurons in both subregions of the Acb in a sex and time-dependent manner. Indeed, pERK-positive neurons were significantly increased in the AcbSh (+ 106%) and AcbC (+ 82%) of male but not female rats, and only at 30 min (upper panel) but not 60 min (lower panel) after WIN administration. In this brain region, ERK activation was not affected by the presence or absence of ovarian hormones, being not significantly different between intact and OVX female rats. One-way ANOVA revealed a significant main effect of Treatment in the AcbSh [F(1,10) = 4.97, P < 0.05] and AcbC [F(1,10) = 6.01, P < 0.05] of male rats at 30 min (upper panel), but failed to detect significant main effects in the AcbSh [F(1,14) = 0.55, P = NS] and AcbC [F(1,14) = 0.08, P = NS] at 60 min (lower panel). It is noteworthy that in both the intact and OVX females oneway ANOVA revealed no significant effect of Treatment in any Acb subregion at any time interval analyzed (Fig. 4) . Effects of vehicle (veh) or WIN (0.3 mg/kg, intravenous) on %pERK-positive neurons/area observed at 30 min after administration in the superficial (left) and deep (right) layers of the CG1 (top panels), PrL (middle panels), and IL (bottom panels) PFCx (n = 6-8/group). Histograms represent the % average SEM. *P < 0.05, Newman-Keuls post-hoc test versus corresponding veh group; # P < 0.05, Newman-Keuls post-hoc test with respect to same treatment groups, different sex; § P < 0.05, Newman-Keuls post-hoc test with respect to same treatment groups, different hormonal status. CG1, cingulate cortex; IL PFCx, infralimbic region of the prefrontal cortex; OVX, ovariectomized female rats; pERK, phosphorylated extracellularsignal-regulated kinase; PFCx, prefrontal cortex; PrL PFCx, prelimbic region of the prefrontal cortex; WIN, WIN55,212-2.
Discussion
This study is the first to investigate the existence of sexdependent differences in pERK following exposure to the cannabinoid receptor agonist WIN. Previous studies on the effects of acute (Valjent et al., 2001; Derkinderen et al., 2003; Rubino et al., 2005) and repeated (Rubino et al., 2007) administrations of cannabinoid agonists were performed mostly in male animals, although sex-dependent differences were reported in endocannabinoid signaling (Melis et al., 2013) and WIN self-administration in Lister Hooded rats (Fattore, 2013; Fattore et al., 2009) . In the present study, we administered to Lister-Hooded rats a dose of WIN very similar to that daily self-administered by trained rats, by the same (intravenous) route (Fattore et al., 2009) .
Interestingly, the same dose of WIN (0.3 mg/kg) was able to reinstate cannabinoid-seeking behavior in rats , supporting the inclusion of the CG1 as the brain region of interest for this study (Kalivas and McFarland, 2003) . Findings showed that WIN differentially activates ERK in the CG1, PFCx, and Acb in a sex hormonal-status brain-region and time-dependent manner.
On the basis of our previous behavioral and electrophysiological studies (Melis et al., 2013) , we aimed in the present study to characterize the potential greater sensitivity of female rats in response to the acute administration of WIN in terms of ERK activation. Unexpectedly, with the single exception of the Effects of vehicle (veh) or WIN (0.3 mg/kg, intravenous) on %pERK-positive neurons/area observed at 60 min after administration in the superficial (left) and deep (right) layers of the CG1 (top panels), PrL (middle panels), and IL (bottom panels) PFCx (n = 6-8/group). Histograms represent the % average SEM. *P < 0.05, Newman-Keuls post-hoc test versus corresponding veh group; # P < 0.05, Newman-Keuls post-hoc test with respect to same treatment groups, different sex. CG1, cingulate cortex; IL PFCx, infralimbic region of the prefrontal cortex; OVX, ovariectomized female rats; pERK, phosphorylated extracellular-signal-regulated kinase; PFCx, prefrontal cortex; PrL PFCx, prelimbic region of the prefrontal cortex; WIN, WIN55,212-2.
cortical (CG1 and PFCx) superficial layers at 30 min, female rats were overall less responsive to WIN-induced pERK than males, which showed increased pERK in CG1 (deep layer), PFCx (superficial and deep layers of both PrL and IL subregions) at 60 min, and in Acb (both AcbSh and AcbC subregions) at 30 min. However, there are some limitations in correlating these findings with the sex differences previously reported in WIN selfadministration . In fact, while in our previous studies female rats learned over time to self-administer WIN and pressed the lever for WIN to a greater extent than males (i.e. active administration), in the present study subjects of both sexes received the same amount of WIN not-contingently (i.e. passive administration). Likewise, repeated self-administration sessions allowed animals to take more WIN over time, whereas in this study animals received only an acute administration of WIN. Therefore, we cannot exclude that repeated self-administration of WIN may induce different neurochemical and molecular adaptations that are unlikely to be the same after a single, passive exposure to the drug. Rubino et al. (2004) showed that in male rats THC increased pERK in the cerebellum and caudate-putamen, but not in the cerebral cortex and Acb, with distinct temporal patterns of pERK expression. We also observed a distinct temporal pattern of ERK activation in male ratsthat is, an increased WIN-induced ERK activation, at 30 min, in the Acb and, at 60 min, in the CG1 and ERK activation. Similarly, in female rats, WIN increased the level of pERK-positive cells only in the superficial layers of CG1 and PFCx at 30 min but not at 60 min, with no significant changes being observed in the Acb at any time interval. A number of factors should be considered when interpreting these differential time-dependent effects. These include sex-dependent differences in drug disposition and pharmacokinetics that could contribute to differences in cannabinoid-induced activation of ERK (Tseng et al., 2004) arising from sexually dimorphic gene expression (Yang et al., 2006) . In line with our previous studies (Rosas et al., , 2016 , we selected the time points for anesthetizing for perfusion on the basis of WIN peak effect on dopamine transmission in the Acb (Fadda et al., 2006) based on the reasoning that pERK may be elicited by drugs of abuse upon increased dopamine transmission (Ibba et al., 2009; Rosas et al., 2014 Rosas et al., , 2016 .
The finding that the increased ERK activation elicited by WIN at 30 min in the superficial layers of CG1 and PFCx of female rats was not evident after ovariectomy suggests that sexual hormones may play a critical influence in the cortical regions investigated. Yet, we did not find significant differences between intact and OVX rats in WIN-induced ERK activation in the Acb, in line with a previous study showing no effect of ovarian hormones on Effect of administration of vehicle (veh) or WIN (0.3 mg/kg, intravenous) on %pERK-positive neurons/area observed at 30 min (top panel) and 60 min (bottom panel) after administration in the AcbSh and AcbC (n = 5-8/group). Histograms represent the %average SEM. *P < 0.05, Newman-Keuls post-hoc test versus corresponding veh group; # P < 0.05, Newman-Keuls post-hoc test with respect to same treatment groups. OVX, ovariectomized female rats; Acb, nucleus accumbens; AcbC, core subregion of the nucleus accumbens; AcbSh, shell subregion of the nucleus accumbens; OVX, ovariectomized female rats; pERK, phosphorylated extracellular-signal-regulated kinase; WIN, WIN55,212-2.
Sex differences in CB-induced ERK Rosas et al. 479 cannabinoid-induced ERK activation in the striatum (Winsauer et al., 2012) .
Overall, the present data strengthen the role played by the ovarian hormones in the effects of cannabinoids, as ovariectomy significantly reduces WIN self-administration in female rats , increases CB1R density and function in selected brain areas (Castelli et al., 2014) , and induces a rapid and persistent ERK activation in developing brain tissue (Singh et al., 1999) . In physiological conditions, circulating levels of estradiol and progesterone fluctuate as a result of the reproductive phase and can regulate gene transcription also by modulating cell signaling pathways including the mitogen-activated protein kinase family. Accordingly, estradiol increases pERK (Singh et al., 1999; Bi et al., 2003) and a biphasic effect of progesterone on ERK activation has been described (Orr et al., 2012) . In light of this evidence, our study indicates the need for further investigations to determine the exact role of sexual steroid hormones in cannabinoid-induced effects on ERK pathway activation. It is noteworthy that the ovariectomy in adult females prevents the sex hormones from exerting activational (transient) but not organizational (permanent) effects on the brain, which in turn could affect the response to cannabinoids (Davis and Fattore, 2015) .
Conclusion
This study adds a rapid and sustained increment of ERK activation to the list of the molecular changes that occur differently, in the male and female brain, after exposure to cannabinoids (Fratta and Fattore, 2013) , and provides molecular insights to the body of literature showing sexdependent differences in the distribution and function of CB1 receptors (Castelli et al., 2014) , tonic endocannabinoid signaling (Melis et al., 2013) , cannabinoid self-administration , reinstatement of cannabinoid-seeking , and other cannabinoid-induced behavioral effects .
